| answer text |
<p>The Department has made no assessment of limits of detection in relation to testing
for the presence of controlled cannabinoids in CBD products. The Home Office approach
is one of caution, that is, that a CBD product is likely to be controlled under the
Misuse of Drugs Act 1971 and the Misuse of Drugs Regulations 2001 (‘the 2001 Regulations’)
if it contains any controlled cannabinoids.</p><p>The term ‘administration’ in the
exempt product definition is not defined by the 2001 Regulations. The Human Medicines
Regulations 2012 provides the following as part of its definition:</p><p>““administer”
means administer to a human being—</p><p> </p><p>(a) orally, by injection, or by introduction
into the body in any other way; or</p><p>(b) by external application (whether or not
by direct application to the body)”</p><p> </p><p>The interpretation of legislation
is ultimately a matter for the courts to decide.</p>
|
 |
